Literature DB >> 6369321

ampC beta-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella.

O Olsson, S Bergström, F P Lindberg, S Normark.   

Abstract

Six ampicillin-resistant clinical isolates of Escherichia coli that hyperproduced the chromosomal ampC beta-lactamase were studied. By DNA sequence analysis, we found that five of them were identical over an entire 449-base-pair sequence and carried a novel strong ampC promoter [Olsson, O., Bergström, S. & Normark, S. (1982) EMBO J. 1, 1411-1416]. Except for one base pair this sequence was identical to that of a low beta-lactamase-producing clinical isolate of Shigella sonnei. Spontaneous one-step mutants of S. sonnei that overproduced the ampC beta-lactamase by 45-fold were characterized and found to be mutated at the single base that distinguishes S. sonnei from the five E. coli hyperproducers. The most likely explanation for this result is that chromosomal DNA was transferred in vivo from Shigella to E. coli across the species barrier.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6369321      PMCID: PMC534379          DOI: 10.1073/pnas.80.24.7556

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  In vivo regulation of chromosomal beta-lactamase in Escherichia coli.

Authors:  B Jaurin; S Normark
Journal:  J Bacteriol       Date:  1979-06       Impact factor: 3.490

2.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

3.  Improved estimation of secondary structure in ribonucleic acids.

Authors:  I Tinoco; P N Borer; B Dengler; M D Levin; O C Uhlenbeck; D M Crothers; J Bralla
Journal:  Nat New Biol       Date:  1973-11-14

Review 4.  E. coli RNA polymerase interacts homologously with two different promoters.

Authors:  U Siebenlist; R B Simpson; W Gilbert
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

5.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

6.  Sequence analysis of adenovirus DNA. I. Nucleotide sequence at the carboxy-terminal end of the gene for adenovirus type 2 hexon.

Authors:  G Akusjärvi; U Pettersson
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

7.  Isolation and characterization of DNA repetitions carrying the chromosomal beta-lactamase gene of Escherichia coli K-12.

Authors:  T Edlund; T Grundström; S Normark
Journal:  Mol Gen Genet       Date:  1979-06-07

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase.

Authors:  S Bergström; S Normark
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

10.  The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation.

Authors:  B Jaurin; T Grundström; T Edlund; S Normark
Journal:  Nature       Date:  1981-03-19       Impact factor: 49.962

View more
  17 in total

1.  High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.

Authors:  L K Siu; Po-Liang Lu; J-Y Chen; F M Lin; Shan-Chwen Chang
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 2.  Class I beta-lactamases. Induction and derepression.

Authors:  I Phillips; K Shannon
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

3.  Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals.

Authors:  Michael R Mulvey; Elizabeth Bryce; David A Boyd; Marianna Ofner-Agostini; Allison M Land; Andrew E Simor; Shirley Paton
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations.

Authors:  Ofer Fridman; Amir Goldberg; Irine Ronin; Noam Shoresh; Nathalie Q Balaban
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

5.  Extended-spectrum-beta-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program.

Authors:  Akemi Kojima; Yoshikazu Ishii; Kanako Ishihara; Hidetake Esaki; Tetsuo Asai; Chitose Oda; Yutaka Tamura; Toshio Takahashi; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli.

Authors:  Antonio Oliver; Linda M Weigel; J Kamile Rasheed; John E McGowan; Patti Raney; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli.

Authors:  E C Nelson; B G Elisha
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals.

Authors:  Laura Briñas; Myriam Zarazaga; Yolanda Sáenz; Fernanda Ruiz-Larrea; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 9.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 10.  Beta-lactam antibiotics: from antibiosis to resistance and bacteriology.

Authors:  Kok-Fai Kong; Lisa Schneper; Kalai Mathee
Journal:  APMIS       Date:  2010-01       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.